Trial Profile
A Phase II Trial of Anastrozole with Celecoxib as First-Line Therapy for Postmenopausal Women with Hormone Receptor Positive Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2016
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary) ; Celecoxib
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 08 Jun 2016 Status changed from active, no longer recruiting to completed.
- 30 Aug 2011 New trial record